Research has examined NNMT inhibition, adipocyte metabolism, NAD+ salvage activity, and cellular energy expenditure in cell and rodent models. The oral format supports route-of-delivery and metabolic study designs.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds 5-Amino-1MQ Capsules appeared first on PrecisionsPeptides.com.

Investigations have addressed BDNF and nerve growth factor expression, neuronal protection under stress, and cognition-related behavioral assays in rodent and cell systems. The nasal format supports absorption and time-course study designs.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds Semax Nasal Spray appeared first on PrecisionsPeptides.com.

Reported research spans glucose regulation, insulin secretion dynamics, appetite-related behavioral assays, and GLP-1 receptor signaling in cell cultures and rodent models. Its defined receptor target supports mechanistic study of incretin biology.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds GLP-1 appeared first on PrecisionsPeptides.com.

Laboratory work has addressed mitochondrial respiration, energy expenditure, fat oxidation, and oxidative-stress responses in cell and rodent systems. Its targeted uncoupling activity makes it a distinctive probe for bioenergetic study designs.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds BAM15 Capsules appeared first on PrecisionsPeptides.com.

Investigations have examined synapse formation, HGF/c-Met pathway signaling, and cognition-related behavioral endpoints in cell and rodent models. Its oral format and metabolic stability make it a practical probe for neuroplasticity research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds Dihexa Capsules appeared first on PrecisionsPeptides.com.

Documented research covers blood-vessel formation, connective-tissue cell behavior, gastrointestinal mucosal protection, and growth-factor signaling in cell and rodent systems. The oral format supports gastrointestinal-route and handling-focused study designs.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds BPC-157 Capsules appeared first on PrecisionsPeptides.com.

Studies have addressed growth hormone and IGF-1 elevation, ghrelin-receptor signaling, appetite-related behavior, and sleep-architecture markers in rodent and cell systems. Its oral activity and long half-life make it a practical probe for sustained GH-axis research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds MK-677 Capsules appeared first on PrecisionsPeptides.com.

Investigations span angiogenesis, cellular motility, extracellular matrix turnover, and inflammatory modulation in cultured systems and animal models. The encapsulated form supports oral-route study designs and simplified handling in laboratory settings.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds TB-500 Capsules appeared first on PrecisionsPeptides.com.

Research applications include angiogenesis, cell motility, matrix remodeling, and inflammatory modulation in cell and animal systems. The nasal format supports bioavailability and absorption-route study designs in laboratory settings.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds TB-500 Nasal Spray appeared first on PrecisionsPeptides.com.

Research has examined melanocortin receptor activation, behavioral response endpoints, and second-messenger signaling in rodent and cell models. The nasal format supports absorption and pharmacokinetic-style study designs in laboratory settings.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds PT-141 Nasal Spray appeared first on PrecisionsPeptides.com.